Recommendations for the Usage of Ketamine and Esketamine
Am J Psychiatry
.
2021 Dec;178(12):1129.
doi: 10.1176/appi.ajp.2021.21060555.
Author
Victor I Reus
1
Affiliation
1
Weill Institute for Neurosciences, University of California San Francisco.
PMID:
34855446
DOI:
10.1176/appi.ajp.2021.21060555
No abstract available
Publication types
Letter
Comment
MeSH terms
Antidepressive Agents / therapeutic use
Depressive Disorder, Treatment-Resistant* / drug therapy
Humans
Ketamine* / therapeutic use
Substances
Antidepressive Agents
Esketamine
Ketamine